Compass Financial Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Compass Financial Management's DGX Position: Q3 2026 in Review
Compass Financial Management held its Quest Diagnostics (DGX) position steady in Q3 2026 at 88 shares worth $20.5K. The position accounts for ﹤0.01% of the portfolio, ranked #948.
Compass Financial Management first reported a position in DGX in Q2 2026 and has held it in 2 quarters since. 1,126 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Compass Financial Management held 88 shares of Quest Diagnostics worth $20.5K as of Q3 2026.
- Compass Financial Management left its Quest Diagnostics share count unchanged in Q3 2026.
- Quest Diagnostics made up ﹤0.01% of Compass Financial Management's portfolio in Q3 2026, its #948 holding.
- Compass Financial Management first reported a position in Quest Diagnostics in Q2 2026 and has held it in 2 quarters since.
- 1,126 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.